Septodont Finalizes Acquisition of Inibsa with Acteon as Partner

Deal News | Nov 25, 2024 | Iberian Lawyer

Septodont Finalizes Acquisition of Inibsa with Acteon as Partner

Septodont, a leader in dental products, in partnership with Acteon, has acquired Laboratorios Inibsa, a pharmaceutical group in Spain, to expand their global market in dental industry. Inibsa, with over 75 years of experience in the healthcare sector, particularly in dental services, offers Septodont an opportunity to enhance its production capacities and growth in key international markets. At the same time, Acteon, as the reference shareholder and involved through the family investment holding Dentressangle, views this acquisition as a strategic move to consolidate its manufacturing capabilities in dental pharmaceuticals across Europe and Asia. This acquisition was facilitated by a team from Dentons, led by Nieves Briz and her team, involving key M&A and regulatory advisors.

Sectors

  • Healthcare and Pharmaceuticals
  • Legal Advisory

Geography

  • Spain – The target company, Inibsa, is located in Barcelona, Spain, and the transaction was managed and executed in this country.
  • Europe – The article mentions the expansion of manufacturing capabilities in Europe as a strategic goal of Acteon post-acquisition.
  • Asia – The article mentions strengthening Acteon's manufacturing position in Asia through this acquisition.

Industry

  • Healthcare and Pharmaceuticals – The article discusses companies involved in the development and manufacturing of products for dental practitioners, positioning them in the healthcare and pharmaceutical industries.
  • Legal Advisory – Dentons' involvement in providing legal advisory for the transaction as a corporate and M&A partner highlights the legal advisory industry.

Financials

    Participants

    NameRoleTypeDescription
    SeptodontBuyerCompanyA leading manufacturer of dental products, acquiring a majority stake in Inibsa.
    ActeonPartner and Reference ShareholderCompanyA leading manufacturer of dental products and medical devices, partnering with Septodont in the acquisition.
    Laboratorios InibsaTarget CompanyCompanyA global pharmaceutical group specializing in products for dental professionals, acquired by Septodont and Acteon.
    DentonsLegal AdvisorCompanyProvided legal advisory services for the acquisition, with a team led by corporate and M&A partner Nieves Briz.
    DentressangleFinancial ContributorCompanyFamily investment holding company providing financial support for Acteon's investment.
    Olivier SchillerCEO of SeptodontPersonCEO of Septodont who commented on the acquisition.
    Markus BoehringerCEO of ActeonPersonCEO of Acteon who commented on the strategic significance of the acquisition.